Table 2 .
Symptom assessment of residents and staff with a positive SARS-CoV-2 PCR-test
| Symptom assessment n (%) | Residents N = 113 | Staff N = 56 | P-value | ||||
|---|---|---|---|---|---|---|---|
| Symptomatic | 65 (57.5) | 51 (91.1) | <0.001 | ||||
| Presymptomatic | 41 (36.3) | 2 | |||||
| Asymptomatic | 7 (5.2) | 3a | |||||
| Cough | 31 (27.4) | 26 (46.4) | 0.014 | ||||
| Dyspnea | 13 (11.5) | 20 (35.7) | <0.001 | ||||
| Fever | 30 (26.5) | 15 (26.8) | 0.974 | ||||
| Saturation | 27 (23.9) | NA | |||||
| Delirium | 16 (14.2) | NA | |||||
| Chills | 4 (3.5) | 22 (39.3) | <0.001 | ||||
| Malaise | 25 (22.1) | 24 (42.9) | 0.005 | ||||
| Fatigue | 19 (16.8) | 42 (75.0) | <0.001 | ||||
| Myalgia | 2 (1.8) | 26 (46.6) | <0.001 | ||||
| Headache | 5 (4.4) | 36 (64.3) | <0.001 | ||||
| Sore throat | 2 (1.8) | 21 (37.5) | <0.001 | ||||
| Nasal congestion | 15 (13.3) | 34 (60.7) | <0.001 | ||||
| Diarrhoea | 10 (8.8) | 14 (25.0) | 0.005 | ||||
| Nausea | 9 (8.0) | 7 (12.5) | 0.343 | ||||
| Diminished intake | 17 (15.0) | 23 (41.1) | <0.001 | ||||
| Loss of smell or taste | 0 | 27 (48.2) | <0.001 | ||||
| Testing strategy | Symptom based N = 39 | Weekly N = 74 | P-value | Symptom based N = 26 | Weekly N = 30 | P-value | |
| Symptomatic, n (%) | 36 (92.3) | 29 (39.2) | <0.001 | 23 (94.6) | 28 (93.3) | 0.763 | |
| Presymptomatic, n (%) | 3 (7.7) | 38 (51.4) | 1 (3.8) | 1 (3.3) | |||
| Asymptomatic, n (%) | 0 | 7 (9.5) | 2a (7.6) | 1 (3.3) |
aTwo staff members did not complete follow-up questionnaire.